Full Text View
Tabular View
No Study Results Posted
Related Studies
Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging
This study has been terminated.
( Slow accrual; study terminated. )
Study NCT00499382   Information provided by M.D. Anderson Cancer Center
First Received: July 10, 2007   Last Updated: August 31, 2009   History of Changes

July 10, 2007
August 31, 2009
September 2004
March 2009   (final data collection date for primary outcome measure)
To compare the results, called an ejection fraction, of PET/CT and NM cardiac scans of heart. [ Time Frame: 5 Years ] [ Designated as safety issue: No ]
The goal of this research study is to compare the results, called an ejection fraction, of PET and NM cardiac scans of your heart. [ Time Frame: 5 Years ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00499382 on ClinicalTrials.gov Archive Site
 
 
 
Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging
Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging

Primary Objective:

  • Evaluate the agreement between radionuclide ventriculography (RNV) and gated F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in calculating left ventricular ejection fraction (LVEF), end diastolic volume (EDV) and end systolic volume (ESV).

Your doctor has ordered a PET/CT scan and a NM scan on you for routine care. By agreeing to take part in this study, you will go through both of these procedures as you normally would.

For both imaging exams, you will be lying on your back. Every effort will be made to make you as comfortable as possible. For theNM cardiac scan, you will be hooked up to a heart monitor that will take a picture every time your heart beats. Your heart will be imaged from several different views. This exam will take about 30 minutes.

The PET/CT cardiac scan will be done after completion of your normally scheduled PET/CT scan. For this scan, you will be hooked to a heart monitor that records the beats of your heart. While this monitor is attached, you will be imaged with the PET/CT scanner. The PET/CT cardiac scan will take about 10-15 minutes after your PET/CT exam is completed.

Both imaging exams will provide a number that corresponds to the percent of blood pushed out of the left ventricle of your heart during a resting state.

Taking part in this study should add between 10-15 additional minutes to your PET/CT visit. This is due to the additional cardiac imaging time.

This is an investigational study. A total of up to 50 patients will take part in this study. All will be enrolled at UTMDACC.

 
Observational
Case-Only, Prospective
Advanced Cancers
  • Procedure: Nuclear Medicine Cardiac Scan
  • Procedure: PET/CT Cardiac Scan
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Terminated
5
March 2009
March 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients undergoing both FDG PET/CT scan and RNV within two weeks interval, whether for initial staging, restaging or to evaluate response to therapy.
  • Patients who would consent to an additional 10-15 minutes acquisition of the gated images after completion of their FDG PET/CT study with the additional radiation exposure.
  • Patients with regular heart rate.

Exclusion Criteria:

  • Blood glucose level above 200 mg/dL.
  • Irregular heart rate.
  • An interval of less than 1 day between the FDG PET/CT scan and RNV.
Both
 
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00499382
Isis W. Gayed, MD/Assistant Professor, U.T.M.D. Anderson Cancer Center
2004-0578
M.D. Anderson Cancer Center
 
Principal Investigator: Isis W. Gayed, MD U.T.M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP